- Home
- LNTH vs CRDO Comparison
LNTH vs CRDO Comparison
Compare LNTH & CRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- CRDO
- Stock Information
- Founded
- LNTH 1956
- CRDO 2008
- Country
- LNTH United States
- CRDO Cayman Islands
- Employees
- LNTH N/A
- CRDO N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CRDO Semiconductors
- Sector
- LNTH Health Care
- CRDO Technology
- Exchange
- LNTH Nasdaq
- CRDO Nasdaq
- Market Cap
- LNTH 3.6B
- CRDO 18.9B
- IPO Year
- LNTH 2015
- CRDO 2022
- Fundamental
- Price
- LNTH $51.12
- CRDO $162.08
- Analyst Decision
- LNTH Strong Buy
- CRDO Strong Buy
- Analyst Count
- LNTH 6
- CRDO 11
- Target Price
- LNTH $85.50
- CRDO $129.91
- AVG Volume (30 Days)
- LNTH 1.5M
- CRDO 5.5M
- Earning Date
- LNTH 11-05-2025
- CRDO 09-03-2025
- Dividend Yield
- LNTH N/A
- CRDO N/A
- EPS Growth
- LNTH N/A
- CRDO N/A
- EPS
- LNTH 3.77
- CRDO 0.67
- Revenue
- LNTH $1,520,653,000.00
- CRDO $600,135,000.00
- Revenue This Year
- LNTH N/A
- CRDO $94.77
- Revenue Next Year
- LNTH $3.24
- CRDO $27.66
- P/E Ratio
- LNTH $13.75
- CRDO $244.26
- Revenue Growth
- LNTH 5.75
- CRDO 175.81
- 52 Week Low
- LNTH $47.25
- CRDO $26.96
- 52 Week High
- LNTH $118.21
- CRDO $168.42
- Technical
- Relative Strength Index (RSI)
- LNTH 35.73
- CRDO 72.63
- Support Level
- LNTH $51.94
- CRDO $116.16
- Resistance Level
- LNTH $55.24
- CRDO $168.14
- Average True Range (ATR)
- LNTH 1.80
- CRDO 7.74
- MACD
- LNTH 0.23
- CRDO 2.39
- Stochastic Oscillator
- LNTH 3.29
- CRDO 87.45
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About CRDO Credo Technology Group Holding Ltd
Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.